factor VIIa

Related by string. Factor VIIa * factoring . factored . factors . Factors . Factoring : CERTAIN MARKET FACTORS SUCH . Risk Factors section . heading Risk Factors . Item 1A Risk Factors / VIIAD . VIIA : coagulation factor VIIa . VIIa . VIIa VIII . factors VIIa * Factor VIIa Factor VIII . recombinant factor VIIa . factor factor VIIa . recombinant Factor VIIa . Factor VIIa inhibitor *

Related by context. All words. (Click for frequent words.) 75 Factor VIIa 73 Leukine ® 72 THR beta agonist 69 osteogenic 69 IAP inhibitor 69 Personalized Immunotherapy 69 kidney urologic 68 targeted radiotherapeutic 68 Vascular endothelial growth 68 Cathepsin S 68 anti tumor necrosis 68 cathepsin K inhibitor 68 Vascular Endothelial Growth 68 ATL# [002] 68 TNF tumor necrosis 68 sargramostim 68 Ecallantide 68 Initiates Enrollment 68 Panzem R 68 pro angiogenic 67 granulocyte macrophage colony stimulating 67 small molecule chemotherapeutic 67 acetonide FA 67 adenosine A2A 67 macrophage colony stimulating 67 Ad5FGF 4 67 non porcine pancreatic 67 EP #R 67 SGLT 67 vapreotide acetate 67 thrombopoietin TPO 67 selective A2A adenosine receptor 67 PDE4 inhibitor 67 interleukin IL -# 67 including eniluracil ADH 67 methylnaltrexone bromide 67 CB2 selective receptor agonist 67 Kamada AAT 67 Xanafide 67 potent suppressor 67 NV1FGF 66 VEGF vascular endothelial 66 Recombinant Human 66 Ganciclovir 66 Zemiva TM 66 INS# [001] 66 Alfacell proprietary ribonuclease 66 inhibit vascular endothelial 66 novel histone deacetylase 66 Lixivaptan 66 XL# anticancer compounds 66 delivers fluocinolone acetonide FA 66 selective androgen receptor modulator 66 prescribed proton pump 66 epothilones 66 mTOR mammalian target 66 Meets Primary Endpoint 66 aurora kinase 66 diarrhea predominant irritable 66 PF # [002] 66 OMP #R# 66 small molecule tyrosine 66 beta 1a 66 Angiotensin converting enzyme 66 Factor VEGF 66 ADAMTS# 66 PDX pralatrexate 66 VEGF inhibitors 66 SinuNase ™ 66 MAXY VII 66 Aurora Kinase 66 AAG geldanamycin analog 65 Aflibercept 65 therapeutic monoclonal antibody 65 Zorbtive TM 65 Panzem R NCD 65 molecular imaging radiopharmaceutical 65 selective inhibition 65 AzaSite Plus 65 Fc fusion protein 65 IMiDs R 65 RhuDex ® 65 Prodarsan R 65 sitaxsentan 65 MTP inhibitor 65 treat chronic sinusitis 65 Squalamine 65 Generx ™ 65 HER1 65 targeted antifolate 65 MGd 65 reslizumab 65 protein tyrosine phosphatase 1B 65 mertansine 65 dasatinib Sprycel 65 TLK# 65 prostanoid 65 CYP#A# CYP#D# 65 TELINTRA 65 Homspera TM 65 A1PI 65 Cleviprex TM clevidipine 65 investigational humanized monoclonal antibody 65 2A receptor agonist 65 Vascular Wrap TM 65 AEG# 65 elotuzumab 65 keratinocyte 65 HuMax TAC 65 recombinant factor VIIa 65 5 HT2A serotonin 65 rThrombin 65 Hematopoietic 65 catheter occlusion 65 Thrombin 65 inverse agonist 65 HDL Selective Delipidation 65 hyaluronidase enzyme 65 cortisol synthesis 65 hypoxia activated prodrug 65 ADP receptor antagonist 65 cMET 65 Flt3 65 Adenoscan R 65 IV Busulfex 65 2 methoxyestradiol 65 EVIZON TM 65 Aviptadil 65 PNP inhibitor 65 RTP #i 65 ® C1 esterase 65 Phase IIb clinical trials 65 small molecule activators 65 R sorafenib tablets 65 PI3K/Akt pathway inhibitor 65 histone deacetylase HDAC 65 LE SN# 65 volociximab 65 thymidylate synthase TS 65 Dalbavancin 65 inhibit oxidative stress 65 pancreatic alpha 65 tolevamer 65 oral prodrug 64 muscarinic receptor agonist 64 Orally administered 64 Initiates Clinical 64 thalidomide Thalomid 64 JAK#/JAK# 64 TÎ ² 4 64 multiple myeloma MM 64 vinorelbine tartrate 64 granulocyte colony stimulating 64 rhFVIIa 64 Janus kinase 64 glial derived neurotrophic 64 NeoLipid R 64 SGLT 2 64 Panzem 64 EVIZON ™ 64 Files IND 64 Janus Kinase 64 vascular disrupting agents 64 humanized monoclonal 64 RhuDex R 64 poly ADP ribose polymerase 64 TRO# 64 rxRNA 64 Sudhir Agrawal D.Phil 64 Varespladib 64 proteasome inhibitor 64 intravenous recombinant 64 Maxy G# 64 Myocet 64 XYOTAX TM 64 MAGE A3 ASCI 64 Trofex 64 Granulocyte Colony Stimulating Factor 64 OvaRex R 64 Immunotherapeutic 64 novel therapeutic antibodies 64 Onconase 64 recombinant plasma 64 liposomal formulation 64 factor Xa 64 acadesine 64 stem cell pluripotency 64 Tß4 64 pan HDAC inhibitor 64 anionic backbone 64 siRNA therapeutic 64 acetylcholinesterase AChE 64 matrix metalloproteases 64 microsomal triglyceride transfer 64 Fibroblast 64 polysaccharide polymer 64 chimeric monoclonal antibody 64 Resten NG 64 humanised monoclonal antibody 64 Technosphere ® 64 FVIIa 64 PDGF B 64 PEGylated Fab fragment 64 lexidronam injection 64 Kuvan R 64 BCG refractory carcinoma 64 XP# XP# 64 torsemide ER 64 Cintredekin Besudotox 64 cholesteryl ester transfer 64 GW# [003] 64 Nektar proprietary 64 JAK2 inhibitor 64 metaglidasen 64 calcitonin gene related 64 selective adenosine 64 Tasimelteon 64 HepDirect prodrug 64 mu opioid receptor antagonist 64 Cytochrome P# 64 JAK inhibitor 64 IMiDs ® 64 Activity Assay 64 oral dihydropyrimidine dehydrogenase DPD 64 poly ethylene glycol PEG 64 NPC 1C 64 mTOR kinase 64 gefitinib Iressa 64 cartilage regeneration 64 #beta HSD1 64 ALTROPANE R 64 soluble tumor necrosis 64 topoisomerase II inhibitor 64 candidate deforolimus 64 Angiocept 64 Neulasta R 64 recombinant Factor VIIa 64 Xcytrin R 64 Angiolix R 64 Octreolin 64 JUVISTA R Human 64 Pathway Inhibitor 64 folate analogue metabolic 64 PGL# 64 Iluvien ® 64 Interferon alpha 64 fibrotic disease 64 dihydrofolate reductase 64 peroxisomal 64 AERx R 64 glucagon receptor 63 sodium thiosulfate STS 63 Tumor Necrosis Factor 63 Interferon beta 63 HDL Mimetic Peptide 63 receptor tyrosine kinase inhibitor 63 opioid induced bowel dysfunction 63 CYT# potent vascular disrupting 63 cetuximab Erbitux R 63 non nucleoside HCV 63 Annexin V 63 molecular chaperone regulation 63 PDGF receptor 63 EVIZON TM squalamine lactate 63 non peptidic protease 63 vesicular monoamine transporter 63 Platelet Derived Growth 63 TBC# 63 gallium containing 63 Prolastin A1PI 63 UPLYSO 63 inhibitor PPI 63 sodium glucose transporter 63 urocortin 2 63 potently inhibit 63 Bucindolol 63 trastuzumab Herceptin R 63 Indomethacin 63 coagulation cascade 63 erlotinib Tarceva ® 63 intranasal formulation 63 KSP inhibitor 63 ALN PCS 63 ENMD # 63 mediated inhibition 63 5 HT4 63 RECOTHROM ® 63 NTDDS 63 Presents Preclinical Data 63 HSP# inhibitor 63 HCV RNA polymerase 63 orally administered inhibitor 63 StemEx 63 Generx TM 63 MEK inhibitor 63 generation purine nucleoside 63 pathophysiological effects 63 novel topoisomerase 63 Angiotensin Converting Enzyme 63 eIF4E 63 PI3K/Akt pathway 63 anti CD3 63 TNF Tumor Necrosis Factor 63 thrombin receptor 63 aldehyde dehydrogenase ALDH2 deficiency 63 alpha folate receptor 63 sodium glucose cotransporter 63 basic fibroblast 63 cysteamine bitartrate 63 trastuzumab DM1 T DM1 63 MET VEGFR2 63 hyaluronidase rHuPH# 63 novel synthetic peptide 63 REP# 63 Atrasentan 63 Tacrolimus 63 reversible inhibitor 63 Pancreate 63 sorafenib tablets 63 Liposomal 63 Octreotide 63 myelodysplastic myeloproliferative diseases 63 antiangiogenic agent 63 PrevOnco ™ 63 GVAX ® 63 cytoprotective 63 histone deacetylase inhibitor 63 thrombin component 63 Fludara ® 63 refractory chronic lymphocytic 63 DOS# 63 antimitotic 63 HDACi 63 peripherally acting 63 secondary hyperparathyroidism 63 adenosine injection 63 Cytotoxic 63 accumulate preferentially 63 MKC# MT 63 Initiate Clinical Trial 63 Civacir 63 Begins Dosing 63 romidepsin novel 63 isoenzyme 63 FLT3 63 nalbuphine ER 63 depsipeptide 63 Pivotal Phase III 63 adult mesenchymal stem 63 candidate TNFerade biologic 63 Potelligent Technology 63 TKM ApoB 63 RH1 63 erlotinib Tarceva R 63 tiapamil 63 Fenretinide 63 SPRYCEL ® 63 Hemophilia B 63 IL# PE#QQR 63 OMNARIS HFA 63 Iloperidone 63 TRANSDUR ® 63 Kepivance 63 sapropterin dihydrochloride Tablets 63 alpha#beta# integrin 63 antiproliferative activity 63 anti CD3 monoclonal 63 dasatinib Sprycel ® 63 fibrin derived 63 IMPDH inhibitor 63 acyclovir Lauriad R 63 pain palliation 63 Excellarate TM 63 uPA 63 ATPace TM 63 Thiarabine 63 JAK2 Inhibitor 63 Archexin 63 metastatic malignant 63 DNA methyltransferase inhibitors 63 non nucleoside inhibitor 63 epothilone 63 ARC# [002] 63 peptidic compound 63 ZFP Therapeutics 63 Interferon gamma 63 R lenalidomide 63 Vascugel 63 GTC recombinant form 63 integrin inhibitor 63 rhThrombin 63 Panzem NCD 63 tyrosine kinase receptor 63 Kosan dependence 63 GTC recombinant human 63 novel oral anticoagulant 63 CRMD# 63 benign prostatic hypertrophy BPH 63 peptide CGRP 63 Anavex #-# 63 personalized dendritic 63 non nucleoside 63 delta isoform 63 E2F 63 bortezomib Velcade 63 GRNOPC1 contains 63 intranasal insulin product 63 Serostim ® 63 overactive bladder AA# 63 Fodosine 63 Pegloticase 63 vWF 63 adipogenic 63 Triapine R 63 sunitinib Sutent 63 somatostatin analogue 63 NAGS deficiency 63 Hedgehog Pathway Inhibitor 63 PEGylated anti 63 Dasatinib 63 Tyrosine Kinase Inhibitor 63 telomerase therapeutic 63 atacicept 63 JAK1 62 GEM OS2 62 Cloretazine ® 62 R Saizen R 62 aerosolized AAT 62 Completes Patient Enrollment 62 Silodosin 62 pharmacokinetic interactions 62 Kinase Inhibitor 62 HER2 overexpression 62 Galantamine 62 Vidaza azacitidine 62 kallikrein 62 mesylate 62 bone morphogenic protein 62 HGS# 62 BRAF kinase 62 NASH Huntington 62 Entereg R 62 selective modulator 62 epigenetic therapies 62 candidate AQ4N 62 Spiegelmer 62 serine protease 62 CB2 receptor 62 oral isotype selective HDAC 62 Inhalation Solution 62 antifibrotic 62 Gemzar ® 62 Thalomid ® 62 radiation sensitizer 62 ARRY # 62 hypereosinophilic syndrome 62 oncolytic virus therapies 62 receptor inhibitor 62 Solazed 62 coronary stent merged 62 hereditary emphysema 62 bone morphogenetic protein 62 ERK1 2 62 biologic therapeutics 62 myelofibrosis polycythemia vera 62 Solazed TM 62 erythropoietic 62 PORxin TM 62 bevacizumab Avastin ® 62 thrombopoietin 62 histone deacetylase HDAC inhibitor 62 selective antagonist 62 siRNA binds 62 Xyfid TM 62 MKC# MKC# PP 62 HuLuc# 62 Epidermal growth 62 small molecule glucokinase 62 NeoLipid TM 62 PDE# inhibitors 62 HepaGam B 62 TOCOSOL Camptothecin 62 MYDICAR ® 62 Gammagard Liquid 62 PEGylated interferon 62 polymerase inhibitor 62 TRIOLEX HE# APOPTONE HE# 62 nephropathic cystinosis 62 plasma kallikrein inhibitor 62 Qutenza TM 62 vinca alkaloid 62 carbohydrate polymer 62 Soliris eculizumab 62 Allovectin 7 r 62 M1 muscarinic 62 Olaparib 62 fibrotic disorders 62 Hsp# Inhibitor 62 cyclooxygenase COX 62 c myc gene 62 thymosin beta 4 62 selective inverse agonist 62 Eculizumab 62 histone deacetylase HDAC inhibitors 62 FOLFOX6 chemotherapy regimen 62 recombinant FVIII 62 monoclonal antibody IgG1 Mab 62 IMiDs ® compound 62 RhuDex TM 62 ProMune 62 SYN# 62 triggers apoptosis programmed 62 Crofelemer budesonide foam 62 RAF kinase 62 novel immunomodulatory 62 R#/MEM # 62 immuno inflammatory 62 COX2 62 small molecule activator 62 NO synthase 62 EndoTAG TM 62 systemic antifungal 62 nilotinib Tasigna ® 62 personalized cellular immunotherapy 62 tranilast 62 PSN# [001] 62 secretory phospholipase A2 62 topical ophthalmic 62 SinuNase TM 62 NS5b 62 LB# [003] 62 antiapoptotic 62 systemically administered 62 Inosine 62 Vascular Disrupting Agent 62 Bruton tyrosine kinase 62 Tumor necrosis factor 62 novel anticancer 62 Nipent R 62 platelet derived growth 62 herpetic keratitis 62 topically administered 62 Selective Electrochemical Tumor Ablation 62 next generation URAT1 62 constipation predominant irritable bowel 62 PI3K/mTOR 62 anti thrombotic 62 Lisofylline 62 glutamic acid decarboxylase 62 p# inhibitor 62 Enzyme Replacement Therapy 62 ospemifene 62 Aganocide ® 62 IX Fc fusion 62 oral ferric iron 62 AdhTAP 62 potent topoisomerase II 62 Romiplostim 62 postoperative ileus POI 62 Oral NKTR 62 MyVax ® 62 PRT# 62 Augment ™ 62 FOLOTYN ® 62 PTP 1B 62 Litx 62 LEUKINE 62 Maribavir 62 coagulation factor VIIa 62 INTERCEPT red 62 Phosphodiesterase 62 systemic immunosuppressive drugs 62 post surgical adhesions 62 Interferon alfa 62 incyclinide 62 partial agonist 62 BrachySil TM 62 Auxilium transmucosal film 62 novel emulsion formulation 62 cytokine receptor 62 PROSTASCINT R 62 CytoFabTM 62 novel L DOS# 62 5 HT2A receptor 62 Tumour Vascular Disrupting Agent 62 Degarelix 62 Liprotamase 62 Glycosylation 62 Micromet BiTE 62 oral anti arrhythmic 62 novel VDA molecule 62 oral salmon calcitonin 62 ACAPODENE TM 62 γ secretase 62 Anturol ® 62 Vidaza ® 62 Receives Orphan Drug Designation 62 EGFR HER2 62 Medoxomil 62 rFactor XIII 62 RECOTHROM R 62 immunomodulatory 62 Initiates Phase II 62 leukocyte adhesion 62 Cannabinor 62 insulin sensitizing 62 HCV protease inhibitors 62 GEM #S 62 Sanvar R 62 Pafuramidine 62 potent cytotoxic 62 Telintra 62 Factor IX 62 Atypical Hemolytic Uremic Syndrome 62 midstage clinical 62 enkephalin 62 novel peptide 62 ocular formulation 62 investigational pharmacologically unique 62 albiglutide 62 Gentamicin Surgical Implant 62 sulfonylhydrazine class 62 Drug Candidate 62 PrevOnco 62 YONDELIS 62 selective phosphodiesterase 62 CCR5 antagonist 62 acute peripheral arterial 62 targets Galectin receptors 62 Akt activation 62 Submits Response 62 developing Zerenex ferric 62 Syntonix 62 cyclin dependent kinase inhibitor 62 visilizumab 62 stromal cell 62 antibody MAb 62 PEGylated 62 inhibit VEGF 62 TLR9 agonist 62 pediatric Crohn disease 62 oral proteasome inhibitor 62 mineralocorticoid receptor 62 Severe Sepsis 62 Chrysalin 62 Fibroblast growth 62 terlipressin 62 therapeutic peptide 62 leukotriene pathway 62 hepatocyte growth 62 Ketotransdel 62 AERx ® 62 Spiegelmer ® 62 Angiotensin 62 5 Fluorouracil 62 intravenous acetaminophen 62 immunomodulatory therapy 62 MolecularBreeding 61 Mipomersen 61 Cardio Vascu Grow 61 mda 7 61 ARIKACE ™ 61 NeuroSTAT ® 61 siRNA therapeutics 61 Reports Preclinical Data 61 Bortezomib 61 Campath ® 61 monocytes macrophages 61 Bazedoxifene 61 vascular endothelial 61 nicotinic alpha 7 61 PANVAC VF 61 Phase #b/#a clinical 61 Bosutinib 61 dexanabinol 61 isoform selective 61 Dacogen decitabine 61 VEGF receptor 61 candidate alferminogene tadenovec 61 Iluvien TM 61 Alferon N 61 Neulasta ® 61 Augment TM 61 OXIGON TM 61 vernakalant hydrochloride 61 injectable formulation 61 Fibrillex TM 61 TRX1 61 RNAi therapeutic targeting 61 factor HGF 61 Initiates Clinical Trial 61 Ceflatonin R 61 defensin mimetic antibiotic 61 Dupuytren Disease 61 humanised antibody 61 Myelodysplastic Syndrome MDS 61 potent antiproliferative 61 capillary leak 61 blood clotting protein 61 substrates inhibitors 61 INTEGRILIN 61 covalently bound 61 Vidaza R 61 TELINTRA R 61 Irinotecan 61 matrix metalloproteinases MMPs 61 Vaprisol 61 CMV vaccine 61 intravesical infusion therapy 61 Marqibo TM 61 DCVax R 61 successfully commercialize Iluvien 61 alkylating agent 61 gamma secretase inhibitor 61 cell adhesion molecule 61 Panzem ® 61 tubulin inhibitor 61 arterial thrombosis 61 ATIR 61 product platforms AZX# 61 Endotis 61 interferon IFN 61 humanized anti 61 SGLT2 inhibitor 61 Anidulafungin 61 XL# XL# 61 Fabry Disease 61 LymphoStat B TM 61 oral ghrelin agonist 61 HIF 1a 61 relapsed leukemia 61 GMX# 61 Cx# [002] 61 highly selective inhibitor 61 DNA methyltransferases 61 delivery polymer matrix 61 essential thrombocythemia ET 61 development peramivir neuraminidase 61 LymphoStat B belimumab 61 antifibrinolytic 61 oxymorphone ER 61 M# rationally 61 Parathyroid hormone 61 vivo validation 61 KL4 Surfactant 61 agonistic human 61 MAXY G# 61 palifermin 61 TRIOLEX ™ 61 elastase 61 alpha interferons 61 anticancer therapy 61 immune modulatory 61 Fluconazole 61 anti secretory 61 Angiotensin II 61 Retinoic Acid 61 rusalatide acetate 61 Aganocide 61 Fleximer R 61 inducible nitric oxide synthase 61 include Phenoptin TM 61 IMA# 61 GelSite R polymer 61 octreotide implant 61 Epstein Barr Virus EBV 61 Pruvel 61 iSONEP ™ 61 cancer immunotherapies 61 XP #L 61 Evoltra ® 61 GRN# 61 selective androgen receptor modulators 61 humanized monoclonal antibody 61 Omacetaxine 61 Behcet uveitis 61 immune modulator 61 antisense oligonucleotide 61 include PLX IBD 61 NS4A 61 neuropathic pain metabolic diseases 61 Enkephalin 61 Pruvel TM 61 Phase III Pivotal 61 Presents Preclinical 61 Antiangiogenic 61 Safinamide 61 MyVax R 61 HuMax HepC TM 61 CYP #A# 61 CA4P 61 Pivotal Phase 61 Epidermal Growth Factor Receptor 61 FUSILEV enhances 61 nucleoside analogues 61 mocetinostat MGCD# 61 selective immunoproteasome inhibitor 61 Valtropin 61 TOCOSOL 61 Simulect 61 Luteinizing Hormone Releasing Hormone 61 cannabinor 61 Belerofon 61 ABLYNX 61 neurology immunology 61 antisense inhibitors 61 Fx #A 61 fusion enhancers 61 DITPA 61 hormone LHRH antagonist 61 topically applied SEPA 61 Smac mimetic 61 cutaneous T 61 TNFalpha 61 Tesamorelin 61 thromboxane A2 61 Cloretazine 61 Thrombin topical Recombinant 61 Tezampanel 61 MKC# 61 SGLT2 61 urate oxidase 61 Romidepsin 61 TNF alpha selectively neutralizing 61 complement inhibitor eculizumab 61 Anticalins R 61 Interferon Beta 61 Mg Usa 61 CDK inhibitor 61 TIMP 1 61 pralatrexate injection folate analogue 61 receptor monoclonal antibody 61 SUTENT ® 61 SPL# Gel vaginal microbicide 61 dopamine D2 61 Vitaxin 61 Cellegesic 61 DGAT1 61 ALN HPN 61 selectively inhibiting 61 Symadex 61 recombinant Factor VIII 61 immune stimulatory 61 Oncaspar 61 tumor lysis syndrome 61 BAY #-# 61 Nexavar sorafenib 61 Initiate Phase 61 bone morphogenetic proteins 61 initiated Phase Ib 61 pigment epithelium derived 61 MEK1 61 Biolimus A9 61 CCR1 61 dextromethorphan quinidine 61 outlicensed 61 Factor Xa inhibitor 61 HQK 61 paclitaxel Taxol ® 61 LEP ETU 61 GPIIb IIIa 61 treat hyperphosphatemia 61 dihydrochloride 61 plasmid encoding 61 glucokinase activator 61 HuMax 61 chondrocyte 61 sorafenib Nexavar 61 ZOLINZA 61 brand ciclesonide HFA 61 Protein Kinase C 61 pan histone deacetylase 61 interleukin IL 61 mGluR2 NAM 61 CINTREDEKIN BESUDOTOX 61 intravenous AAT 61 etanercept Enbrel 61 histone deacetylase 61 XmAb 61 patented Bioral 61 PLK1 SNALP 61 Curaxin 61 Aliskiren 61 thetreatment 61 RANK Ligand 61 generation antisense inhibitor 61 Antithrombin 61 Hos2 61 Elvitegravir 61 Zybrestat 61 GnT 4a 61 Leukine 61 cromolyn sodium 61 DNA intercalator 61 GSK# [002] 61 ATRA IV 61 TRANSDUR ™ 61 IMiD 61 chronic eosinophilic leukemia 61 lintuzumab SGN 61 dihydrochloride Tablets 61 Bafetinib 61 pharmacological chaperone 61 Patients Treated With 61 pamidronate 61 huC# DM4 61 apoptosis proteins 61 Dapagliflozin 61 PTH analogue 61 Zemiva ™ 61 immunostimulatory 61 colony stimulating factor 61 Unit Dose Budesonide 61 sirtuin modulators 61 skeletal sarcomere activators 61 humanized monoclonal antibodies 61 Increlex TM 61 humanized antibody 61 PDGFR 61 IRX 2 61 upregulates 61 doxercalciferol 61 refractory gout 61 nitric oxide synthase 61 Eluting Stent 61 humanized therapeutic 61 rhMBL 61 CG# [003] 61 Pegylated 61 endothelin receptor antagonists 61 converting enzyme 61 Xelox 61 small molecule Hedgehog 61 Renvela ® 61 SNALP technology 61 receptor activator 61 Calcitonin 61 Anticalins ® 61 VEGFR2 inhibitor 61 mediated apoptosis 61 histamine dihydrochloride 61 NS4B 61 delta opioid receptor 61 targeting Inflammatory Bowel 61 Nexavar ® 61 heparanase 60 Somatuline R Depot 60 delta gamma agonist 60 deforolimus 60 hyperphosphorylation 60 Vorinostat 60 metastatic neuroendocrine tumors 60 immuno modulatory 60 nicotinic acetylcholine receptor 60 GGF2 60 XOMA 3AB 60 liposomal doxorubicin 60 commercialize ZYFLO CR 60 Cyclosert TM 60 Emezine 60 PDGF BB 60 markets HP Acthar 60 SNT MC# 60 factor TNF receptor 60 Fibrin MB 60 methionine aminopeptidase 60 Mg Uk 60 ALK inhibitor 60 Cytarabine 60 Talabostat 60 valtorcitabine 60 ELADUR TM 60 topical antifungal 60 nucleoside analog 60 5 HT6 receptor 60 Luveris R Ovidrel R 60 RAS RAF MEK 60 Intravitreal 60 Initiates Phase III 60 GeneICE 60 Ostabolin C TM 60 Proellex TM 60 syndrome overactive bladder 60 Veronate R 60 Insegia 60 theranostic 60 gemcitabine Gemzar 60 Ovitrelle R Serostim 60 abnormal p# 60 Dose Ranging Study 60 IL 1Ra 60 oral nucleoside analogue 60 Adentri 60 Azedra TM 60 somatostatin analog 60 Camvia 60 diagnostic radiopharmaceutical 60 mitotic kinesin 60 Aurora kinase

Back to home page